Osiris Therapeutics appoints R. Alberto Avendano as CMO
Dr. Avendano brings to Osiris his expertise in medical education and communication, academic and industry clinical research, pharmacovigilance and regulatory affairs.
Dr. Avendano received his license to practice medicine almost 30 years ago. From June 2013 until joining Osiris, he served as the Medical Director for Indivior Inc. (previously Reckitt Benckisser Pharmaceuticals).
Prior to joining Indivior, Dr. Avendano served in a variety of medical director and research positions, most recently as Associate Medical Director at EMD Serono, Inc. ■
LATEST MOVES FROM Maryland
- Choice Hotels appoints Keith Biumi as regional vice president
- GlycoMimetics appoints Scott Koenig to board
- MTGE appoints Steven W. Abrahams to board
- Choice Hotels appoints Dominic E. Dragisich as CFO
- Community Financial Corp. names two directors
More inside POST